Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
STAT3 is an attractive therapeutic target but its homology with other STAT proteins complicates the development of selective inhibitors. Here, the authors develop monobodies with high affinity and selectivity for STAT3 and show that they can interfere with cellular STAT3 activity.
Guardado en:
Autores principales: | Grégory La Sala, Camille Michiels, Tim Kükenshöner, Tania Brandstoetter, Barbara Maurer, Akiko Koide, Kelvin Lau, Florence Pojer, Shohei Koide, Veronika Sexl, Laure Dumoutier, Oliver Hantschel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/709f9a713ee849dc860cc5c099ffede8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The carboxy terminal coiled-coil modulates Orai1 internalization during meiosis
por: Rawad Hodeify, et al.
Publicado: (2021) -
Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly
por: Georgios N. Hatzopoulos, et al.
Publicado: (2021) -
Maintaining and breaking symmetry in homomeric coiled-coil assemblies
por: Guto G. Rhys, et al.
Publicado: (2018) -
Artificial coiled coil biomineralisation protein for the synthesis of magnetic nanoparticles
por: Andrea E. Rawlings, et al.
Publicado: (2019) -
Designed folding pathway of modular coiled-coil-based proteins
por: Jana Aupič, et al.
Publicado: (2021)